Inactive Instrument

News Ocean Biomedical, Inc. Nasdaq

Equities

OCEA

US67644P1057

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease	16/05	AQ
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K	25/04	AQ
Ocean Biomedical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/04	CI
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL	28/03	AQ
Ocean Biomedical, Inc. Appoints Amy Griffith as Director	09/03	CI
Ocean Biomedical, Inc. Announces CFO Changes	05/03	CI
Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting	29/02	AQ
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA	27/02	AQ
North American Morning Briefing : S&P 500 Futures -2-	23/02	DJ
North American Morning Briefing : Central Bankers -2-	17/01	DJ
North American Morning Briefing : Stocks to -2-	10/01	DJ
North American Morning Briefing : Stock Futures Extend Losses as FOMC Minutes Awaited	03/01	DJ
North American Morning Briefing : S&P 500 Futures Dip with Fresh Record in Sight	20/12	DJ
North American Morning Briefing : Traders Await -2-	13/12	DJ
Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody	05/12	AQ
Ocean Biomedical Announces Publication of Breast Cancer Research Uncovering New Tumor Suppression Pathway for its Proprietary Anti-Chi3L1 Antibody	05/12	CI
Ocean Biomedical Receives Non-Compliance Notice From Nasdaq	30/11	MT
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q	30/11	AQ
North American Morning Briefing : Stock Futures -2-	29/11	DJ
North American Morning Briefing : Stock Futures Muted; Nvidia Slips in Offhours Trading	22/11	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ocean Biomedical, Inc. Nasdaq

Equities

OCEA

US67644P1057

Summary

Filters